Placebo + TAVAPADON + TRIMETHOBENZAMIDE HYDROCHLORIDE for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Feb 2015: Trial registered, NCT02373072

The trials

NCT02373072: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

State
Completed
Phase
Phase 1
People
18 taking part
Started
Mar 2015
Primary completion
Feb 2016
Arms
Cohort 1, Cohort 2
Results
None posted
  1. 26 Feb 2015: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.